To build relations trustworthy relations with patients, stakeholders and general public, Ipsen is guided by a policy of transparency in every aspect of its interactions with healthcare professionals and organizations. We are committed to being compliant with the ethical rules applicable to the pharmaceutical industry.
Interactions between industries and health professionals are a positive driver for the development of patient treatment and value of research advancements in patient care and progression of innovative medicines.
The Society has increasingly high expectations especially on healthcare matters. We want to make sure that we meet these expectations, and for this purpose we are keen to ensure this relationship is understood by patients, the media, other stakeholders, and more generally the public.
This transparency approach, covered by the professional Codes of the industry to which Ipsen fully subscribes, requires the publication of payments made to health actors.
Ipsen Senior Vice President,
Chief Ethics and Compliance Officer
Interactions between the pharmaceutical industry and health actors have a profound and positive influence on the quality of patient’s treatment and the value of future research. At the same time, the integrity of the decision of healthcare professionals to prescribe a medicine is one of the pillars of the healthcare system, and must be free of any conflict of interest.
To ensure this independence, the European Federation of Pharmaceutical Industries and Associations (EFPIA) agreed the EFPIA Disclosure Code, which requires the public disclosure of payments to healthcare professionals and organizations starting 2016 (for payments made in 2015).
In this context, Ipsen is dedicated to promoting transparency by providing a clear view, to all its stakeholders, of its interactions with healthcare professionals and healthcare organizations. We deeply believe this is the right way to build a collaborative relationship with the healthcare professionals, based on respect, independence, integrity and transparency.
Please follow the links to the countries to find the information about local Transparency rules and reports:
- Czech Republic
- The Netherlands
Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to HCPs/HCOs our company is collaborating/has relationships with, following the objectives and provisions included in the applicable codes. Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable codes that our company signed off to.
These publications do not grant a general permission for those accessing our website or the national platforms to undertake additional processing of the healthcare professionals’ data.
For a good understanding of the reporting included in our disclosures as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.